Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

Alprazolam Tablets

Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.

Terminated Impurity / degradation The Harvard Drug Group NDC 0904-5858-61 D-0013-2018
Class III · Low risk

Ampicillin for Injection

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Terminated Labeling / mix-up Sandoz Inc NDC 0781-3407-78 D-1179-2017
Class II · Moderate risk

methylPREDNIsolone ACETATE

Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

Terminated Sterility / contamination RXQ Compounding LLC D-0012-2018
Class III · Low risk

Mobic (meloxicam)

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Terminated Labeling / mix-up Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0030-01 D-0007-2018
Class II · Moderate risk

Medline Skin Stapler RMVR

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0314-2018
Class II · Moderate risk

Medline Anesthesia Kit

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0306-2018

Recalls by year